Gng5 function in neural progenitors
Gng5 在神经祖细胞中的功能
基本信息
- 批准号:8360905
- 负责人:
- 金额:$ 8.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-01 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAdenylate CyclaseAdultAffectAllelesAmericanAmino AcidsAnimalsBiological ProcessBrainBypassCell physiologyCharacteristicsChildCommunitiesCommunity DevelopmentsCongenital DisordersCongenital Heart DefectsDefectDegenerative DisorderDevelopmentDiseaseEmbryoEventExhibitsFoundationsFutureG Protein GeneG-Protein-Coupled ReceptorsGTP-Binding ProteinsGene FamilyGene TargetingGenesGoalsGuanosine TriphosphateHealthHeterotrimeric GTP-Binding ProteinsHuman GenomeIndividualIon ChannelKnock-outKnockout MiceMaintenanceMicrocephalyMolecularMolecular ProfilingMusNational Institute of Child Health and Human DevelopmentNational Institute of Neurological Disorders and StrokeNeurodegenerative DisordersNeuronsNeurosciencesOrganismPhospholipasePlayPost-Translational Protein ProcessingProcessProductionProtein SubunitsProteinsRegulationResearchResourcesRoleSecond Messenger SystemsSignal PathwaySignal TransductionTransgenic MiceTranslatingaging populationbasedesigndimerimprovedinsightmigrationmouse genomemouse modelnerve stem cellnervous system disordernestin proteinneural precursor cellneurodevelopmentneurogenesisneuron lossneurotrophic factornovelpreventprogramspromoterrecombinaserelating to nervous systemsecond messengerselective expression
项目摘要
DESCRIPTION (provided by applicant): Understanding how the normal brain develops and what goes wrong in disease is fundamental for designing better ways to prevent congenital diseases, and to treat degenerative disorders marked by neuronal loss. Of particular relevance to this application, there is a growing recognition that heterotrimeric G proteins are critical for
formation and maintenance of the brain. They produce bifurcating signals in the form of a GTP- subunit and a dimer that regulate phospholipases, adenylyl cyclases, and ion channels to produce the "second messengers" responsible for modulating many neuronal processes. The current challenge is to relate the individual G-protein subtypes to their regulation of particular processes. Both expression and functional evidence suggest the Gng5 gene encoding the G-protein gamma5 subunit plays a critical role in modulating proliferation, migration, or differentiation. Gng5 is preferentially expressed in neural progenitor cells. Moreover, we have shown that global deletion of Gng5 causes microcephaly. However, the information that can be obtained from studying the global knockout mice has been limited by their early embryonic lethality resulting from a cardiac defect. Consistent with the stated purpose of the R03 mechanism, this application proposes to develop a conditional knockout mouse model in which Gng5 is specifically deleted in neural progenitor cells. This will be accomplished by crossing mice carrying two floxed Gng5 alleles with transgenic mice expressing Cre-recombinase under control of the nestin promoter. Subsequently, histological analyses of conditional knockout brains will be performed to identify how loss of the G-protein ?5 subunit affects cortical size and
organization, while molecular strategies will be used to elucidate any underlying defects in proliferation, migration, or differentiation of neural progenitor cells. Revealing the signaling pathways requiring the G-protein ?5 subunit that is responsible for neural progenitor cell expansion, migration, or differentiation may provide a molecular basis for the future development of effective strategies to prevent congenital disorders and treat neurodegenerative diseases.
PUBLIC HEALTH RELEVANCE:
To improve the health of the American people, the goal of both NINDS and NICHD are to gain a better understanding of how the normal brain develops, and to translate these discoveries into better strategies to prevent congenital disorders, and to more effectively treat neurodegenerative disorders. This R03 application addresses both goals by providing a novel mouse model for studying how heterotrimeric G proteins are involved in formation and maintenance of brain. This resource will have inherent value to both the neuroscience and development communities.
描述(由申请人提供):了解正常大脑如何发育以及疾病中出现的问题是设计更好的方法来预防先天性疾病和治疗以神经元丧失为标志的退行性疾病的基础。与此应用特别相关的是,越来越多的人认识到异源三聚体G蛋白对
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JANET D ROBISHAW其他文献
JANET D ROBISHAW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JANET D ROBISHAW', 18)}}的其他基金
Beta/Gamma Subunit Heterogeniety in G Proteins
G 蛋白中的 β/γ 亚基异质性
- 批准号:
7913465 - 财政年份:2009
- 资助金额:
$ 8.18万 - 项目类别:
G PROTEIN BETA GAMMA SIGNALING SYSTEMS IN VIVO
体内 G 蛋白 Beta GAMMA 信号系统
- 批准号:
6319617 - 财政年份:1998
- 资助金额:
$ 8.18万 - 项目类别:
G protein beta gamma Signaling Systems in Vivo
体内 G 蛋白 beta gamma 信号系统
- 批准号:
6776055 - 财政年份:1998
- 资助金额:
$ 8.18万 - 项目类别:
G PROTEIN BETA GAMMA SIGNALING SYSTEMS IN VIVO
体内 G 蛋白 Beta GAMMA 信号系统
- 批准号:
6019499 - 财政年份:1998
- 资助金额:
$ 8.18万 - 项目类别:
G PROTEIN BETA GAMMA SIGNALING SYSTEMS IN VIVO
体内 G 蛋白 Beta GAMMA 信号系统
- 批准号:
2687632 - 财政年份:1998
- 资助金额:
$ 8.18万 - 项目类别:
G protein beta gamma Signaling Systems in Vivo
体内 G 蛋白 beta gamma 信号系统
- 批准号:
7207967 - 财政年份:1998
- 资助金额:
$ 8.18万 - 项目类别:
G PROTEIN BETA GAMMA SIGNALING SYSTEMS IN VIVO
体内 G 蛋白 Beta GAMMA 信号系统
- 批准号:
6386999 - 财政年份:1998
- 资助金额:
$ 8.18万 - 项目类别:
G PROTEIN BETA GAMMA SIGNALING SYSTEMS IN VIVO
体内 G 蛋白 Beta GAMMA 信号系统
- 批准号:
6180804 - 财政年份:1998
- 资助金额:
$ 8.18万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 8.18万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 8.18万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 8.18万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 8.18万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 8.18万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 8.18万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 8.18万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 8.18万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 8.18万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 8.18万 - 项目类别:
Research Grant














{{item.name}}会员




